Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

✍ Scribed by B. Ramaswamy; W. Fiskus; B. Cohen; C. Pellegrino; D. L. Hershman; E. Chuang; Thehang Luu; G. Somlo; M. Goetz; R. Swaby; C. L. Shapiro; V. Stearns; P. Christos; I. Espinoza-Delgado; K. Bhalla; J. A. Sparano

• Book ID: 113062384
• Publisher: Springer US
• Year: 2011
• Tongue: English
• Weight: 592 KB
• Volume: 132
• Category: Article
• ISSN: 0167-6806
• DOI: 10.1007/s10549-011-1928-x